Organizing the medical care for the COVID-19 patients in non-infectious Moscow hospital: reassignment experience

Abstract

Aim. To present the results of work of National Medical Research Center of Treatment and Rehabilitation, reassigned for COVID-19 patients’ treatment during pandemic. Run-up methodology, procedures and working process organization are detailed.

Materials and methods. 354 COVID-19 patients were treated from 13.04.2020 to 10.06.2020 [age 59 (4–70) years, 56% women, body mass index 28.5 (24.9–32.2) kg/m2]. Patients were admitted at 8 (6–11) day of sickness. In-hospital stay was 16 (14–20) days.

Results. NEWS scale at the day of admittance was 2 (1–4); 2 (1–3) in patients discharged alive and 6 (4–7) in died patients, p=0.0001. So prognostic accuracy of NEWS scale was confirmed as very well (area under ROC-curve = 0.819). 69 patients (19.5%) were treated at intensive care department for 7 (4–13) days. 13 patients died, 11 of them had COVID-19 as direct or indirect cause of death. Total in-hospital mortality was 3.67%, in-hospital mortality of COVID-19 patients – 3.1%. 17 healthcare workers (HCW), contacted with COVID-19 patients were infected (2.67%). 4 HCW, who had no direct contact with patients were also infected and 7 HCW were infected before the first patient was admitted. No one of them died.

Conclusion. Complex tasks of healthcare organization during COVID-19 pandemic can be solved quickly with acceptable quality, characterized by low levels of patients; mortality and HCW infection.

About the authors

I. G. Nikitin

National Medical Research Center of Treatment and Rehabilitation; Pirogov Russian National Research Medical University

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0003-1699-0881

д.м.н., проф., дир. ФГАУ НМИЦ ЛРЦ, зав. каф. госпитальной терапии №2 лечебного фак-та ФГАОУ ВО «РНИМУ им. Н.И. Пирогова»

Russian Federation, Moscow

A. V. Melekhov

National Medical Research Center of Treatment and Rehabilitation; Pirogov Russian National Research Medical University

Author for correspondence.
Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-1637-2402

д.м.н., доц., гл. терапевт ФГАУ НМИЦ ЛРЦ.

Russian Federation, Moscow

M. A. Sayfullin

National Medical Research Center of Treatment and Rehabilitation; Pirogov Russian National Research Medical University

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-7419-9874

к.м.н., доц. каф. инфекционных болезней у детей педиатрического фак-та ФГАОУ ВО «РНИМУ им. Н.И. Пирогова», инфекционист ФГАУ НМИЦ ЛРЦ

Russian Federation, Moscow

S. S. Agafonov

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-7419-9874

зав. отд-нием эндоскопии

Russian Federation, Moscow

S. A. Bedritskiy

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-9733-6445

зав. отд-нием функциональной диагностики

Russian Federation, Moscow

A. A. Vishninskiy

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-5796-7739

зав. отд-нием ультразвуковой диагностики

Russian Federation, Moscow

N. A. Gultiaeva

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-5917-0077

зав. приемным отд-нием

Russian Federation, Moscow

E. R. Guseynov

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-8693-6114

зав. поликлиникой

Russian Federation, Moscow

N. A. Ermakov

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-1271-7960

к.м.н., зам. дир. по хирургии

Russian Federation, Moscow

E. A. Zorin

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-0624-540X

к.м.н., зав. хирургическим отд-нием

Russian Federation, Moscow

Iu. V. Koroleva

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-9354-0828

зав. отд-нием анестезиологии и реанимации №2

Russian Federation, Moscow

D. V. Kudryavtsev

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru

зав. отд-нием кардиореанимации

Russian Federation, Moscow

A. P. Manevskiy

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0003-1739-8556

д.м.н., первый зам. дир

Russian Federation, Moscow

A. A. Negovskiy

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-6582-6565

зав. отд-нием анестезиологии и реанимации №1

Russian Federation, Moscow

V. S. Petrovichev

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-8391-2771

к.м.н., зав. отд-нием томографии

Russian Federation, Moscow

B. E. Rudakov

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-4033-3737

к.м.н., рук. Центра восстановительной медицины и реабилитации

Russian Federation, Moscow

A. I. Ruleva

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-3515-2325

эпидемиолог

Russian Federation, Moscow

A. B. Serebryakov

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-0122-0588

к.м.н., зав. ортопедическим отд-нием

Russian Federation, Moscow

A. R. Sitnikov

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-7309-0391

к.м.н., зав. нейрохирургическим отд-нием

Russian Federation, Moscow

N. F. Fedosova

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-0813-4279

к.м.н., зав. клин.-диагностич. лаб.

Russian Federation, Moscow

E. V. Khammad

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-5038-8726

к.м.н., зав. отд-нием терапии №2

Russian Federation, Moscow

A. A. Avramov

National Medical Research Center of Treatment and Rehabilitation

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-6055-3289

анестезиолог

Russian Federation, Moscow

A. I. Agaeva

Pirogov Russian National Research Medical University

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0001-7559-135X

студент

Russian Federation, Moscow

K. Y. Golubykh

Pirogov Russian National Research Medical University

Email: AMelekhov@med-rf.ru
ORCID iD: 0000-0002-4093-4639

студент

Russian Federation, Moscow

References

  1. Ресурсы и деятельность медицинских организаций здравоохранения. Коечный фонд (число и обеспеченность населения койками различных специальностей). Ч. III. Москва, 2020 г. [Resources and services of medical healthcare organizations. Bed stock (number and provision of the population with beds of various specialties). Part III. Moscow 2020 (In Russ.)]. https://mednet.ru/miac/meditsinskaya-statistika от 21.07.2020
  2. Приказ Министерства здравоохранения РФ от 19 марта 2020 г. №198н «О временном порядке организации работы медицинских организаций в целях реализации мер по профилактике и снижению рисков распространения новой коронавирусной инфекции COVID-19». [Order of the Ministry of Health of the Russian Federation from March 19, 2020, № 198n «About the temporary procedure for organizing the work of medical organizations in order to implement measures to prevent and reduce the risks of the spread of a new coronavirus infection COVID-19» (In Russ.)]. https://www.garant.ru/products/ipo/prime/doc/73669697/
  3. Распоряжение Правительства РФ от 2 апреля 2020 г. №844-р «Об утверждении перечней организаций и их структурных подразделений, осуществляющих медицинскую деятельность, подведомственных федеральным органам исполнительной власти, и частных медицинских организаций, которые перепрофилируются для оказания медицинской помощи пациентам с подтвержденным диагнозом новой коронавирусной инфекции COVID-19 или с подозрением на новую коронавирусную инфекцию COVID-19 в стационарных условиях» [Order of the Government of the Russian Federation from April 2, 2020, № 844-r “About the approval of the lists of organizations and their structural subdivisions carrying out medical services, subordinate to federal executive authorities and private medical organizations that are being reassigned for provision of medical care to patients with a confirmed diagnosis of new coronavirus infection COVID-19 or with suspicion for new coronavirus infection COVID-19 in the inpatient settings» (In Russ.)]. http://www.garant.ru/hotlaw/federal/1343391/
  4. Письмо Министерства здравоохранения РФ от 24.03.2020 №30-1/10/2-24 «О минимальных требованиях к зданиям и помещениям, где планируется организация дополнительных инфекционных коек для лечения пациентов с COVID-19» [Letter of the Ministry of Health of the Russian Federation from 24.03.2020 № 30-1/10/2-24 «About the minimal requirements for buildings and premises where it is planned to organize additional infectious beds for the treatment of patients with COVID-19» (In Russ.)]. https://www.garant.ru/products/ipo/prime/doc/73754076/
  5. Royal College of Physicians. National Early Warning Score (NEWS): Standardising the assessment of acute-illness severity in the NHS. Report of a working party. London: RCP, 2012. www.rcplondon.ac.uk/file/32/download?token=5NwjEyTq
  6. Sbiti-Rohr D, Kutz A, Christ-Crain M, et al. The National Early Warning Score (NEWS) for outcome prediction in emergency department patients with community-acquired pneumonia: results from a 6-year prospective cohort study. BMJ Open. 2016;6:e011021. doi: 10.1136/bmjopen-2015-011021
  7. Астафьева М.Н., Багин В.А., Молдованов А.В. и др. Сравнение шкал qSOFA, NEWS и критериев SIRS в прогнозе исходов у пациентов приемного отделения в зависимости от наличия инфекции: результаты проспективного наблюдательного исследования. Клин. микробиология и антимикроб. химиотерапия. 2019;21(1)18-25. doi: 10.36488/cmac.2019.1.18-25 [Astafyeva MN, Bagin VA, Moldovanov AV, et al. Comparison of the qSOFA and NEWS scores and the SIRS criteria in predicting outcomes in emergency department patients with and without infection: results from a prospective observational study. Clinical microbiology and antimicrobial chemotherapy. 2019;21(1):18-25 (In Russ.)]. doi: 10.36488/cmac.2019.1.18-25
  8. Wahidi MM, Lamb C, Murgu S, et al. American Association for Bronchology and Interventional Pulmonology (AABIP) statement on the use of bronchoscopy and respiratory specimen collection in patients with suspected or confirmed COVID-19 infection. J Bronchology Interv Pulmonol. 2020;24(4):52-4. doi: 10.1097/LBR.0000000000000681
  9. СанПиН 2.1.7.2790-10. Санитарно-эпидемиологические требования к обращению с медицинскими отходами (утверждены Главным государственным санитарным врачом РФ 09.12.2010) [SanPiN 2.1.7.2790-10. Sanitary and Epidemiological Requirements for Medical Waste Management (approved by the Chief State Sanitary Doctor of the Russian Federation from 09.12.2010 (In Russ.)]. http://base.garant.ru/12183219/
  10. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Временные методические рекомендации. Версия 7 от 03.06.2020 [Prevention, diagnosis, and treatment of new coronavirus infection (COVID-19). Temporary guidelines. Version 7 dated from 06/03/2020 (In Russ.)]. https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_COVID-19_v7.pdf
  11. Анестезиолого-реанимационное обеспечение пациентов с новой коронавирусной инфекцией COVID-19. Методические рекомендации, 2020 [Anesthetic and resuscitation services for patients with the new coronavirus infection COVID-19. Methodological recommendations, 2020 (In Russ.)]. https://edu.rosminzdrav.ru/fileadmin/user_upload/specialists/COVID-19/dop-materials/11_05_2020/Metreki_FAR.pdf
  12. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-81. doi: 10.1001/jama.2020.5394
  13. Lara Álvarez MÁ, Rogado Revuelta J, Obispo Portero B, et al. COVID-19 mortality in cancer patients in a Madrid hospital during the first 3 weeks of the epidemic. Med Clin (Barc). 2020;155(5):202-4. doi: 10.1016/j.medcli.2020.05.005
  14. Ayerbe L, Risco C, Ayis S. The association between treatment with heparin and survival in patients with Covid-19. J Thromb Thrombolysis. 2020;50(2):298-301. doi: 10.1007/s11239-020-02162-z
  15. Borobia AM, Carcas AJ, Arnalich F, et al. A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe. J Clin Med. 2020;9(6):E1733. doi: 10.3390/jcm9061733
  16. Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919-26. doi: 10.1016/S0140-6736(20)31173-9
  17. Palaiodimos L, Kokkinidis DG, Li W, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262
  18. Rosenberg ES, Dufort EM, Udo T, et al. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. JAMA. 2020;323(24):2493-502. doi: 10.1001/jama.2020.8630.
  19. Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524. doi: 10.1183/13993003.00524-2020
  20. Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002
  21. Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324-29. doi: 10.1111/jth.14859
  22. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-8. doi: 10.1016/j.jaci.2020.04.006
  23. Rastad H, Karim H, Ejtahed HS, et al. Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease. Diabetol Metab Syndr. 2020;12:57. doi: 10.1186/s13098-020-00565-9
  24. Lai X, Wang M, Qin C, et al. Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China. JAMA Netw Open. 2020;3(5):e209666. doi: 10.1001/jamanetworkopen.2020.9666
  25. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi: 10.1001/jama.2020.2648
  26. Wong SC, Kwong RT, Wu TC, et al. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect. 2020;105(2):119-27. doi: 10.1016/j.jhin.2020.03.036
  27. Kluytmans M, Buiting A, Pas S, et al. SARS-CoV-2 infection in 86 healthcare workers in two Dutch hospitals in March 2020. medRxiv. 2020:2020.03.23.20041913. doi: 10.1101/2020.03.23.20041913
  28. Fusco FM, Pisaturo M, Iodice V, et al. COVID-19 infections among Healthcare Workers in an Infectious Diseases specialized setting in Naples, Southern Italy: results of a cross-sectional surveillance study. J Hosp Infect. 2020;105(4):596-600. doi: 10.1016/j.jhin.2020.06.021
  29. Team CC-R. Characteristics of health care personnel with COVID-19 – United States, February 12 – April 9, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):477-81. doi: 10.15585/mmwr.mm6915e6
  30. Hunter E, Price DA, Murphy E, et al. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020;395(10234):e77-8. doi: 10.1016/S0140-6736(20)30970-3

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies